Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/24869
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | JANSSENS, Kris | - |
dc.contributor.author | MAHESHWARI, Anurag | - |
dc.contributor.author | Vandenhaute, Chris | - |
dc.contributor.author | STRUYS, Tom | - |
dc.contributor.author | LAMBRICHTS, Ivo | - |
dc.contributor.author | Baekelandt, Veerle | - |
dc.contributor.author | STINISSEN, Piet | - |
dc.contributor.author | HENDRIKS, Jerome | - |
dc.contributor.author | Slaets, Helena | - |
dc.contributor.author | HELLINGS, Niels | - |
dc.date.accessioned | 2017-09-29T07:26:52Z | - |
dc.date.available | 2017-09-29T07:26:52Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | GLIA, 65, p. E438-E438 (Art N° T14-042A) | - |
dc.identifier.issn | 0894-1491 | - |
dc.identifier.uri | http://hdl.handle.net/1942/24869 | - |
dc.description.sponsorship | We wish to acknowledge FWO Flanders, the Belgian Charcot Foundation and the Belgian MS Liga for funding this research. | - |
dc.language.iso | en | - |
dc.publisher | WILEY | - |
dc.title | Oncostatin M signaling is essential for robust remyelination | - |
dc.type | Journal Contribution | - |
local.bibliographicCitation.conferencedate | JUL 08-11, 2017 | - |
local.bibliographicCitation.conferencename | 13th European Meeting on Glial Cells in Health and Disease | - |
local.bibliographicCitation.conferenceplace | Edinburgh, SCOTLAND | - |
dc.identifier.epage | E438 | - |
dc.identifier.spage | E438 | - |
dc.identifier.volume | 65 | - |
local.format.pages | 1 | - |
local.bibliographicCitation.jcat | M | - |
dc.description.notes | [Janssens, K.; Maheshwari, A.; Struys, T.; Lambrichts, I.; Stinissen, P.; Hendriks, J.; Slaets, H.; Hellings, N.] Hasselt Univ, Biomed Res Inst, Hasselt, Belgium. [Vandenhaute, C.; Baekelandt, V.] Katholieke Univ Leuven, Leuven, Belgium. | - |
local.publisher.place | HOBOKEN | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
local.bibliographicCitation.artnr | T14-042A | - |
dc.identifier.isi | 000403071700675 | - |
item.accessRights | Closed Access | - |
item.contributor | JANSSENS, Kris | - |
item.contributor | MAHESHWARI, Anurag | - |
item.contributor | Vandenhaute, Chris | - |
item.contributor | STRUYS, Tom | - |
item.contributor | LAMBRICHTS, Ivo | - |
item.contributor | Baekelandt, Veerle | - |
item.contributor | STINISSEN, Piet | - |
item.contributor | HENDRIKS, Jerome | - |
item.contributor | Slaets, Helena | - |
item.contributor | HELLINGS, Niels | - |
item.fulltext | No Fulltext | - |
item.fullcitation | JANSSENS, Kris; MAHESHWARI, Anurag; Vandenhaute, Chris; STRUYS, Tom; LAMBRICHTS, Ivo; Baekelandt, Veerle; STINISSEN, Piet; HENDRIKS, Jerome; Slaets, Helena & HELLINGS, Niels (2017) Oncostatin M signaling is essential for robust remyelination. In: GLIA, 65, p. E438-E438 (Art N° T14-042A). | - |
crisitem.journal.issn | 0894-1491 | - |
crisitem.journal.eissn | 1098-1136 | - |
Appears in Collections: | Research publications |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.